Executive Profile

Marvin Konstam M.D. Chief Scientific Officer, Cardiovascular Clinical Studies, Inc.

Age	Total Calculated Compensation	This person is connected to 1 Board Members in 1 different organizations across 3 different industries. See Board Relationships
--	--

Background

Dr. Marvin A. Konstam, M.D. serves as the Chief Scientific Officer of Cardiovascular Clinical Studies, Inc. and CareGuide, Inc. Dr. Konstam has been the Medical Director of ORQIS Medical Corporation since 2003. He is a Professor of Medicine (cardiology) and Professor of Radiology at Tufts University School of Medicine and Tufts-New England Medical Center (now Tufts Medical Center) continuously since 1981. He is Chief Physician Executive of The Cardiovascular Center, ... at Tufts Medical Center. He serves as the Chief of Cardiology and Director of Cardiovascular Development of New England Medical Center. Dr. Konstam is a cardiology specialist with vast experience in academic medicine and research. He served as the Chief of Cardiology at Tufts-NEMC from 1997 to 2007. In 2008, Dr. Konstam served as Senior Advisor for Cardiovascular Diseases at the National Heart, Lung, and Blood Institute, providing direction to the NHLBI's extramural cardiovascular research programs. He served as the President of the Heart Failure Society of America from 2002 to 2004, during which time he initiated the HFSA's Research Fellowship Program and played a lead role in driving the American Board of Internal Medicine's establishment of Advanced Heart Failure and Transplant Cardiology as a secondary subspecialty of Cardiology. His research has been published extensively in leading peer-reviewed medical journals and he lectured throughout the world on such topics as ventricular remodeling in heart failure, drug treatment and strategies for improving the quality of care. He consulted for the Centers for Medicare and Medicaid Services with regard to their programs for improving quality of care in heart failure. He has more than 14 years of experience as a specialist in the field of cardiovascular system medical devices. Dr. Konstam's principal clinical interest is heart failure and his principal areas of investigation are ventricular remodeling in heart failure, novel pharmaceutical and device treatment for heart failure, and strategies for improving quality of Cardiovascular care. He serves as Member of the Clinical Advisory Board of Cardioxyl Pharmaceuticals, Inc. He serves as Member of Medical Advisory Board of CareGuide, Inc. He has served as a member of the Cardiovascular and Renal Advisory Panel of the Food and Drug Administration. He served as Member of scientific advisory board of NovaCardia, Inc. He was lead author and committee chair for the Agency for Health Care Policy and Research (presently AHRQ) Clinical Practice Guideline on the care of patients with heart failure, and has served on the Heart Failure Guideline panels of the American Heart Association/American College of Cardiology and of the Heart Failure Society of America. He graduated from the College of Physicians and Surgeons, Columbia University, and did his post-graduate training at the Massachusetts General Hospital and Brigham and Womens' Hospital.

Corporate Headquarters 75 Kneeland Street Boston, Massachusetts 02111 United States Phone: 617-423-7999 Fax: 617-423-7034 Board Members Memberships There is no Board Members Memberships data available. Education Unknown/Other Education Edward S. Harkness Eye Institute MD Edward S. Harkness Eye Institute Unknown/Other Education Brigham and Women's Hospital Other Affiliations ORQIS Medical Corporation NovaCardia, Inc. Brigham and Women's Hospital Edward S. Harkness Eye Institute Cardioxyl Pharmaceuticals, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.